Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for SWTX
| Stock Name | SpringWorks Therapeutics Inc |
| Ticker | SWTX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US85205L1070 |
Show aggregate SWTX holdings
News associated with SWTX
- Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in SpringWorks Therapeutics (NASDAQ:SWTX)
- Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 10,846 shares of the company’s stock, valued at approximately $479,000. Other institutional investors have also recently modified their holdings of the […] - 2025-08-04 05:14:49
- Cwm LLC Acquires 1,923 Shares of SpringWorks Therapeutics (NASDAQ:SWTX)
- Cwm LLC boosted its holdings in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 832.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,154 shares of the company’s stock after purchasing an additional 1,923 shares during the quarter. Cwm LLC’s holdings in […] - 2025-08-01 05:01:05
- Envestnet Asset Management Inc. Sells 7,489 Shares of SpringWorks Therapeutics (NASDAQ:SWTX)
- Envestnet Asset Management Inc. cut its stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 6.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,274 shares of the company’s stock after selling 7,489 shares during the period. Envestnet Asset Management Inc.’s […] - 2025-07-25 04:42:59
- Victory Capital Management Inc. Cuts Stock Position in SpringWorks Therapeutics (NASDAQ:SWTX)
- Victory Capital Management Inc. lowered its stake in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 29.6% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 432,951 shares of the company’s stock after selling 181,972 shares during the quarter. Victory Capital Management Inc.’s holdings in SpringWorks Therapeutics were worth $19,106,000 as of its most recent […] - 2025-07-23 05:12:55
- SpringWorks Therapeutics (NASDAQ:SWTX) Shares Sold by Principal Financial Group Inc.
- Principal Financial Group Inc. lowered its position in SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 3.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,064,109 shares of the company’s stock after selling 39,749 shares during the period. Principal Financial […] - 2025-07-07 05:54:49
- SpringWorks Therapeutics (NASDAQ:SWTX) Shares Sold by Exchange Traded Concepts LLC
- Exchange Traded Concepts LLC decreased its stake in shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) by 45.7% in the 1st quarter, HoldingsChannel.com reports. The firm owned 2,556 shares of the company’s stock after selling 2,153 shares during the quarter. Exchange Traded Concepts LLC’s holdings in SpringWorks Therapeutics were worth $113,000 at the end of […] - 2025-06-25 05:28:58
- SpringWorks Therapeutics (NASDAQ:SWTX) Receives $52.57 Consensus Target Price from Brokerages
- SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokers […] - 2025-06-20 02:20:17
- State of Wyoming Boosts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- State of Wyoming grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 39.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,530 shares of the company’s stock after purchasing an additional 433 shares during the quarter. State of Wyoming’s […] - 2025-05-29 04:47:00
- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Recommendation of “Hold” from Brokerages
- Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average […] - 2025-05-23 04:22:52
- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Bank of America Corp DE
- Bank of America Corp DE reduced its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 51.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 416,888 shares of the company’s stock after selling 444,322 shares during the quarter. Bank of America Corp DE’s holdings in SpringWorks Therapeutics were worth $15,062,000 at the end […] - 2025-05-22 04:40:51
- SpringWorks Therapeutics (NASDAQ:SWTX) Receives Neutral Rating from Guggenheim
- SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “neutral” rating restated by equities research analysts at Guggenheim in a research note issued to investors on Monday,Benzinga reports. They presently have a $47.00 price target on the stock. Guggenheim’s price target points to a potential upside of 1.69% from the company’s current price. A […] - 2025-05-14 02:36:44
- Northern Trust Corp Acquires 52,908 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Northern Trust Corp grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 8.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 655,678 shares of the company’s stock after purchasing an additional 52,908 shares during the period. Northern Trust […] - 2025-05-13 05:31:21
- Dimensional Fund Advisors LP Lowers Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Dimensional Fund Advisors LP reduced its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 1.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 717,714 shares of the company’s stock after selling 7,403 shares during the period. Dimensional Fund Advisors LP’s holdings in SpringWorks Therapeutics were worth $25,931,000 as […] - 2025-05-07 05:24:51
- SpringWorks Therapeutics (NASDAQ:SWTX) Receives Hold Rating from TD Cowen
- SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “hold” rating restated by analysts at TD Cowen in a report released on Tuesday, Marketbeat Ratings reports. They presently have a $47.00 price objective on the stock, down from their previous price objective of $66.00. TD Cowen’s price target would suggest a potential upside of […] - 2025-05-01 04:48:58
- SpringWorks Therapeutics (NASDAQ:SWTX) Lowered to “Hold” Rating by Evercore ISI
- Evercore ISI lowered shares of SpringWorks Therapeutics (NASDAQ:SWTX – Free Report) from a strong-buy rating to a hold rating in a report released on Monday,Zacks.com reports. A number of other research firms have also commented on SWTX. HC Wainwright restated a “buy” rating and issued a $74.00 price target on shares of SpringWorks Therapeutics in […] - 2025-05-01 02:37:02
- Pre-Market Most Active for Apr 28, 2025 : TSLL, PFE, BBAI, INTC, NVDA, TSLA, SWTX, TQQQ, AMPY, SCHW, ABBV, NIO
- The NASDAQ 100 Pre-Market Indicator is down -14.2 to 19,418.36. The total Pre-Market volume is currently 170,511,986 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.27 at $10.72, with 25,789,199 s - 2025-04-28 09:28:55
- Envestnet Asset Management Inc. Grows Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Envestnet Asset Management Inc. raised its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 1.3% in the fourth quarter, Holdings Channel reports. The fund owned 121,763 shares of the company’s stock after buying an additional 1,507 shares during the period. Envestnet Asset Management Inc.’s holdings in SpringWorks Therapeutics were worth $4,399,000 as of […] - 2025-04-24 04:26:48
- Russell Investments Group Ltd. Cuts Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Russell Investments Group Ltd. lowered its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 19.4% in the 4th quarter, HoldingsChannel reports. The firm owned 112,942 shares of the company’s stock after selling 27,251 shares during the quarter. Russell Investments Group Ltd.’s holdings in SpringWorks Therapeutics were worth $4,081,000 as of its most recent […] - 2025-04-16 05:39:00
- Norges Bank Invests $6.74 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Norges Bank bought a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 186,503 shares of the company’s stock, valued at approximately $6,738,000. Norges Bank owned 0.25% of SpringWorks Therapeutics as […] - 2025-04-09 04:53:04
- Corebridge Financial Inc. Sells 2,579 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Corebridge Financial Inc. reduced its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 7.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,178 shares of the company’s stock after selling 2,579 shares during the quarter. Corebridge Financial Inc.’s holdings in SpringWorks Therapeutics […] - 2025-04-04 04:37:00
- Teacher Retirement System of Texas Increases Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Teacher Retirement System of Texas increased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 26.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,609 shares of the company’s stock after buying an additional 3,674 shares during the period. Teacher Retirement […] - 2025-03-31 04:28:57
- Cibc World Markets Corp Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Cibc World Markets Corp acquired a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,433 shares of the company’s stock, valued at approximately $232,000. Other large investors also recently […] - 2025-03-27 05:54:53
- Swiss National Bank Acquires 8,000 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Swiss National Bank grew its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 7.4% during the fourth quarter, Holdings Channel reports. The firm owned 116,800 shares of the company’s stock after purchasing an additional 8,000 shares during the period. Swiss National Bank’s holdings in SpringWorks Therapeutics were worth $4,220,000 as of […] - 2025-03-26 05:42:52
- M&T Bank Corp Grows Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- M&T Bank Corp lifted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 16.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,155 shares of the company’s stock after purchasing an additional 2,774 shares during the period. […] - 2025-03-13 06:35:36
- Assetmark Inc. Acquires 2,196 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Assetmark Inc. grew its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 4.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 48,216 shares of the company’s stock after acquiring an additional 2,196 shares during the quarter. Assetmark Inc.’s holdings in […] - 2025-03-11 06:20:55
- Oppenheimer Asset Management Inc. Cuts Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)
- Oppenheimer Asset Management Inc. lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The fund owned 12,559 shares of the company’s stock after selling 837 shares during the period. Oppenheimer Asset Management Inc.’s holdings in SpringWorks Therapeutics were worth $454,000 at the end of the […] - 2025-03-06 09:03:36
- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Bought by State of New Jersey Common Pension Fund D
- State of New Jersey Common Pension Fund D raised its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 19.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 55,343 shares of the company’s stock after buying an additional 8,954 shares during the period. State of New Jersey Common Pension […] - 2025-02-24 07:16:49
- Analysts Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) PT at $70.83
- Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […] - 2025-02-19 05:55:37
- Contrasting SpringWorks Therapeutics (NASDAQ:SWTX) and Innate Pharma (OTCMKTS:IPHYF)
- SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) and Innate Pharma (OTCMKTS:IPHYF – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares SpringWorks Therapeutics and Innate […] - 2025-02-13 06:46:56
- Investors Purchase Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX)
- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) was the recipient of some unusual options trading activity on Monday. Stock investors purchased 5,756 call options on the stock. This represents an increase of 721% compared to the average volume of 701 call options. Analyst Ratings Changes A number of analysts have commented on SWTX shares. […] - 2025-02-12 04:15:00
iShares MSCI World Small Cap UCITS ETF USD (Acc) SWTX holdings
| Date | Number of SWTX Shares Held | Base Market Value of SWTX Shares | Local Market Value of SWTX Shares | Change in SWTX Shares Held | Change in SWTX Base Value | Current Price per SWTX Share Held | Previous Price per SWTX Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of SWTX by Blackrock for IE00BF4RFH31
Show aggregate share trades of SWTX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-06-30 | BUY | 328 | | | 46.990* | | 41.92 |
| 2025-06-25 | BUY | 492 | | | 46.970* | | 41.83 |
| 2025-06-20 | SELL | -83 | | | 46.960* | | 41.74  Profit of 3,464 on sale |
| 2025-06-12 | SELL | -664 | | | 46.760* | | 41.55 Profit of 27,592 on sale |
| 2025-06-02 | BUY | 249 | | | 46.670* | | 41.29 |
| 2025-05-28 | BUY | 166 | | | 46.680* | | 41.18 |
| 2025-05-14 | BUY | 82 | | | 46.220* | | 40.83 |
| 2025-05-13 | BUY | 164 | | | 46.220* | | 40.79 |
| 2025-05-07 | BUY | 249 | | | 46.200* | | 40.64 |
| 2025-04-28 | BUY | 82 | | | 46.180* | | 40.34 |
| 2025-04-16 | BUY | 1,079 | | | 37.740* | | 40.35 |
| 2025-04-14 | BUY | 166 | | | 37.460* | | 40.39 |
| 2025-04-08 | SELL | -166 | | | 35.710* | | 40.54 Profit of 6,730 on sale |
| 2025-04-04 | SELL | -166 | | | 39.090* | | 40.59 Profit of 6,737 on sale |
| 2025-03-28 | BUY | 830 | | | 47.410* | | 40.43 |
| 2025-03-12 | SELL | -166 | | | 50.880* | | 39.36 Profit of 6,534 on sale |
| 2025-03-04 | SELL | -164 | | | 51.380* | | 38.79 Profit of 6,362 on sale |
| 2025-02-26 | SELL | -328 | | | 54.140* | | 38.10 Profit of 12,495 on sale |
| 2025-02-13 | BUY | 83 | | | 58.590* | | 36.01 |
| 2025-02-12 | BUY | 332 | | | 59.280* | | 35.72 |
| 2025-01-27 | BUY | 84 | | | 35.820* | | 34.87 |
| 2025-01-23 | BUY | 84 | | | 36.140* | | 34.84 |
| 2025-01-08 | SELL | -588 | | | 40.490* | | 34.47 Profit of 20,268 on sale |
| 2024-12-18 | BUY | 336 | | | 36.000* | | 34.37 |
| 2024-12-09 | BUY | 3,024 | | | 41.870* | | 34.08 |
| 2024-12-04 | BUY | 168 | | | 42.310* | | 33.58 |
| 2024-12-03 | BUY | 252 | | | 42.550* | | 33.39 |
| 2024-11-19 | BUY | 504 | | | 37.930* | | 31.09 |
| 2024-11-18 | BUY | 168 | | | 34.560* | | 30.98 |
| 2024-11-12 | BUY | 336 | | | 33.100* | | 30.92 |
| 2024-11-11 | BUY | 84 | | | 33.520* | | 30.75 |
| 2024-11-11 | BUY | 84 | | | 33.520* | | 30.75 |
| 2024-11-07 | BUY | 420 | | | 33.090* | | 30.31 |
| 2024-11-07 | BUY | 420 | | | 33.090* | | 30.31 |
| 2024-10-23 | BUY | 168 | | | 28.610* | | 30.14 |
| 2024-10-23 | BUY | 168 | | | 28.610* | | 30.14 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of SWTX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-06-30 | 154,185 | 0 | 1,245,538 | 12.4% |
| 2025-06-27 | 227,057 | 0 | 2,033,952 | 11.2% |
| 2025-06-26 | 183,567 | 0 | 417,018 | 44.0% |
| 2025-06-25 | 119,324 | 0 | 267,201 | 44.7% |
| 2025-06-24 | 129,386 | 1,100 | 408,343 | 31.7% |
| 2025-06-23 | 398,261 | 0 | 908,604 | 43.8% |
| 2025-06-20 | 620,878 | 0 | 2,651,316 | 23.4% |
| 2025-06-18 | 398,589 | 0 | 939,820 | 42.4% |
| 2025-06-17 | 150,262 | 0 | 270,094 | 55.6% |
| 2025-06-16 | 289,551 | 0 | 680,566 | 42.5% |
| 2025-06-13 | 185,913 | 0 | 606,144 | 30.7% |
| 2025-06-12 | 188,931 | 0 | 446,310 | 42.3% |
| 2025-06-11 | 226,823 | 24 | 614,826 | 36.9% |
| 2025-06-10 | 101,517 | 0 | 256,789 | 39.5% |
| 2025-06-09 | 174,728 | 0 | 417,499 | 41.9% |
| 2025-06-06 | 104,477 | 0 | 209,917 | 49.8% |
| 2025-06-05 | 435,787 | 0 | 741,695 | 58.8% |
| 2025-06-04 | 475,042 | 0 | 729,516 | 65.1% |
| 2025-06-03 | 100,101 | 0 | 459,035 | 21.8% |
| 2025-06-02 | 233,610 | 0 | 973,001 | 24.0% |
| 2025-05-30 | 354,163 | 0 | 501,108 | 70.7% |
| 2025-05-29 | 126,749 | 0 | 386,530 | 32.8% |
| 2025-05-28 | 244,025 | 0 | 1,100,688 | 22.2% |
| 2025-05-27 | 196,295 | 1,050 | 529,911 | 37.0% |
| 2025-05-23 | 383,602 | 0 | 1,527,640 | 25.1% |
| 2025-05-22 | 215,891 | 0 | 379,804 | 56.8% |
| 2025-05-21 | 446,679 | 83 | 957,267 | 46.7% |
| 2025-05-20 | 129,664 | 0 | 273,935 | 47.3% |
| 2025-05-19 | 207,147 | 0 | 490,871 | 42.2% |
| 2025-05-16 | 816,779 | 6,698 | 2,638,855 | 31.0% |
| 2025-05-15 | 605,865 | 5,472 | 1,839,103 | 32.9% |
| 2025-05-14 | 734,421 | 1,541 | 1,073,165 | 68.4% |
| 2025-05-13 | 366,496 | 0 | 816,870 | 44.9% |
| 2025-05-12 | 1,562,850 | 2,757 | 3,333,856 | 46.9% |
| 2025-05-09 | 384,358 | 0 | 617,141 | 62.3% |
| 2025-05-08 | 591,924 | 0 | 1,228,237 | 48.2% |
| 2025-05-07 | 339,402 | 0 | 1,528,907 | 22.2% |
| 2025-05-06 | 643,691 | 0 | 1,340,706 | 48.0% |
| 2025-05-05 | 236,172 | 20,433 | 640,154 | 36.9% |
| 2025-05-02 | 337,077 | 1,255 | 1,916,429 | 17.6% |
| 2025-05-01 | 279,230 | 140 | 1,993,786 | 14.0% |
| 2025-04-30 | 795,672 | 5,963 | 3,154,978 | 25.2% |
| 2025-04-29 | 1,259,426 | 382,408 | 6,260,855 | 20.1% |
| 2025-04-28 | 6,212,824 | 15,327 | 26,455,518 | 23.5% |
| 2025-04-25 | 1,540,057 | 4,691 | 3,643,929 | 42.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy